Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study
- Tasavon Gholamhoseini M. , et al.
2. An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study
- Mirzazadeh A. , et al.
3. New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years
- Dennis B.B. , et al.
4. Direct-acting antiviral agents in the treatment of chronic hepatitis C—Real-life experience from clinical practices in Pakistan
- Mushtaq S. , et al.
5. A simple risk-based strategy for hepatitis C virus screening among incarcerated people in a low- To middle-income setting
- Hariri S. , et al.
6. Hepatitis C: How Good Are Real-Life Data and Do Generics Work
- Tran A.N. , et al.
7. The hepatitis C virus in Iran: Health policy, historical, ethical issues and future challenges
- Behzadifar M. , et al.
8. Decentralized care with generic direct-acting antivirals in the management of chronic hepatitis C in a public health care setting
- Dhiman R.K. , et al.
9. An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE study
- Alavi M. , et al.
10. Status of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection and Remaining Challenges
- Baumert T.F. , et al.
11. Comparison of prevention, screening and treatment of hepatitis C in Iran, Egypt and Georgia
- Behzadifar M. , et al.
12. Update on recommendations for the clinical management of hepatitis C in Iran 2017
- Alavian S.M. , et al.
13. Chronic Hepatitis C: Do Generics Work as Well as Branded Drugs?
- Premkumar M. , et al.